Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ig: Low vs Usual Dose IVIg in Blood Cancers
NCT07202065Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Apr 2025
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in hypogammaglobulinemia, sponsored by Monash University. Started Apr 2025; status: recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
hypogammaglobulinemia
Beyond the preview
Go deeper on NCT07202065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07202065.